Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Gap junction | R-HSA-190861 | map04540 | riluzole | 5070 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | riluzole | 5070 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | riluzole | 5070 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | riluzole | 5070 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfamethoxazole | 5329 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | sulfamethoxazole | 5329 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulfamethoxazole | 5329 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | sulfamethoxazole | 5329 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sulfamethoxazole | 5329 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfamethoxazole | 5329 | drug-path |
Asthma | R-HSA-444620 | map05310 | sulfamethoxazole | 5329 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | sulfamethoxazole | 5329 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | sulfamethoxazole | 5329 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfamethoxazole | 5329 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | sulfamethoxazole | 5329 | drug-path |
Shigellosis | 0 | map05131 | sulfamethoxazole | 5329 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | sulfamethoxazole | 5329 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfamethoxazole | 5329 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | sulfamethoxazole | 5329 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | sulfamethoxazole | 5329 | drug-path |